4.2 Article

Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm

期刊

CURRENT ALZHEIMER RESEARCH
卷 13, 期 5, 页码 566-574

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1567205013666160120151457

关键词

Atrophy; automated segmentation; classification models; freesurfer; hippocampal subfields; mild cognitive impairment; volumetry

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering
  4. Alzheimer's Association
  5. Alzheimer's Drug Discovery Foundation
  6. Araclon Biotech
  7. BioClinica, Inc.
  8. Biogen Idec Inc.
  9. Bristol-Myers Squibb Company
  10. Eisai Inc.
  11. Elan Pharmaceuticals, Inc.
  12. Eli Lilly and Company
  13. EuroImmun
  14. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  15. Fujirebio
  16. GE Healthcare
  17. IXICO Ltd.
  18. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  19. Johnson & Johnson Pharmaceutical Research & Development LLC.
  20. Medpace, Inc.
  21. Merck Co., Inc.
  22. Meso Scale Diagnostics, LLC.
  23. NeuroRx Research
  24. Neurotrack Technologies
  25. Novartis Pharmaceuticals Corporation
  26. Pfizer Inc.
  27. Piramal Imaging
  28. Synarc Inc.
  29. Takeda Pharmaceutical Company
  30. Canadian Institutes of Health Research
  31. Servier
  32. NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Although measurement of total hippocampal volume is considered as an important hallmark of Alzheimer's disease (AD), recent evidence demonstrated that atrophies of hippocampal subregions might be more sensitive in predicting this neurodegenerative disease. The vast majority of neuroimaging papers investigating this topic are focused on the difference between AD and patients with mild cognitive impairment (MCI), not considering the impact of MCI patients who will or not convert in AD. For this reason, the aim of this study was to determine if measurements of hippocampal subfields provide advantages over total hippocampal volume for discriminating these groups. Hippocampal subfields volumetry was extracted in 55 AD, 32 converted and 89 not-converted MCI (c/nc-MCI) and 47 healthy controls, using an atlas-based automatic algorithm based on Markov random fields embedded in the Freesurfer framework. To evaluate the impact of hippocampal atrophy in discriminating the insurgence of AD-like phenotypes we used three classification methods: Support Vector Machine, Naive Bayesian Classifier and Neural Networks Classifier. Taking into account only the total hippocampal volume, all classification models, reached a sensitivity of about 66% in discriminating between c-MCI and nc-MCI. Otherwise, classification analysis considering all segmenting subfields increased accuracy to diagnose c-MCI from 68% to 72%. This effect resulted to be strongly dependent upon atrophies of the subiculum and presubiculum. Our multivariate analysis revealed that the magnitude of the difference considering hippocampal subfield volumetry, as segmented by the considered atlas-based automatic algorithm, offers an advantage over hippocampal volume in distinguishing early AD from nc-MCI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据